RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+33.62%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.2B
AUM Growth
+$1.2B
(+8%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
1.29%
Top 10 Holdings %
Top 10 Hldgs %
81.29%
Holding
35
New
8
Increased
4
Reduced
6
Closed
8
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$75M |
| 2 |
InflaRx
IFRX
|
$60.3M |
| 3 |
scPharmaceuticals
SCPH
|
$34.5M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$22.9M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$19.5M |
Top Sells
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
$50.7M |
| 2 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$50.1M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$37.6M |
| 4 |
Insmed
INSM
|
$22.6M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$21.3M |
Sector Composition
| 1 | Healthcare | 96.25% |
